Labidia, Anjielica C.

HRN: 22-78-11  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/24/2023
CEFAZOLIN 1GM (VIAL)
03/25/2023
03/25/2023
IV
2grams
On Call To OR ANST
For EL USO, Left With BTL
Waiting Final Action 
03/25/2023
CEFAZOLIN 1GM (VIAL)
03/25/2023
03/26/2023
IV
1 G
Q12x 2 Doses
Left Ovarian New Growth Sp USO
Waiting Final Action 
03/26/2023
CEFUROXIME 500MG (TAB)
03/26/2023
04/02/2023
PO
500mg
BID X 7 Days
S/P Pelvic Laparotomy: Left Oophorectomy
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: